History doesn’t repeat, but it rhymes. The National Stock Exchange of India (NSE) is heading toward a record-breaking IPO, valued at approximately $57 billion. That alone signals a market at peak optimism. But what catches my attention isn’t the size of the raise—it’s the rare sell recommendation issued by Dolat Capital just ahead of the listing. In a market where every other analyst is waving the “India story” flag, a homegrown institution is stepping back and saying: “this isn’t worth it.”
Context matters here. NSE isn’t just another exchange; it’s the backbone of India’s equity market. Its monopoly-like position in cash equities and derivatives makes it a trophy asset for any global portfolio. The IPO’s $57 billion valuation implies a forward P/E that rivals the world’s most expensive exchanges—and does so in a high-interest-rate environment where the Reserve Bank of India (RBI) remains hawkish. Dolat’s sell rating is not an outlier; it’s a structural alarm from a firm that knows the local terrain intimately.
The core insight is this: The valuation repackages India’s macro promise into a premium that may already be priced to perfection. Over the past five years, I’ve seen this pattern before—during the 2017 ICO boom, when whitepapers promised “decentralized everything” at billion-dollar valuations. I audited over 200 projects back then and passed on 95% of them—not because the technology was flawed, but because the tokenomics were built on regressive liquidity models that couldn’t survive a bear market. My due diligence filter told me that narrative and timing were being confused with substance. The same filter is ringing now. NSE’s revenue depends on trading volumes, which are cyclical and sensitive to global liquidity flows. In a world where the Fed’s next move is uncertain, paying a 40–50x earnings multiple for a volume-dependent monopoly is a bet on uninterrupted growth—a bet that history rarely rewards.
Let me frame this through a crypto lens, because the dynamics are eerily similar. When a centralized exchange token (like BNB or, hypothetically, a future Coinbase token) trades at a massive premium relative to its earnings, the market is buying the idea that transaction volume will compound indefinitely. That works until it doesn’t. The 2022 Terra-Luna collapse taught me that liquidity dries up faster than sentiment catches up. I profited from that panic because I understood that “froth” is a tax on late arrivals. Volatility is the fee for admission to the future. NSE’s IPO is no different. Investors are paying for a future that may be fully discounted.
Now, the contrarian angle: Dolat’s sell rating may actually be a bullish signal for the broader Indian market—or at least a sign of maturity. A sell rating on the country’s most prestigious IPO suggests that local capital is not blindly following the herd. This is what healthy markets do: they allow dissent. In crypto, we rarely see a major exchange give a sell rating on a token before its listing. The lack of institutional short-selling mechanisms creates echo chambers of forced optimism. Dolat’s action is a reminder that traditional markets still have ventilation. The true risk is not that the sell rating is correct, but that it becomes a self-fulfilling prophecy—especially if other global sell-side firms follow suit.
My experience during the 2020 DeFi yield crisis reinforced this. When yields on protocols like Compound and Aave hit unsustainable triple-digit APYs, I redirected capital away from the farm and into protocol-generated revenue streams like Uniswap fees. Everyone thought I was missing out. Six months later, the exploits hit, and my fund was intact. Risk isn’t what you can see; it’s what you don’t know to look for. In NSE’s case, what investors may not see is the growing threat from alternative trading platforms, regulatory tightening by SEBI, and a potential shift in global capital flows away from emerging markets if the dollar strengthens further.
What this means for positioning: The sell rating is a useful anchor for setting expectations. If NSE’s IPO prices at the lower end of the range, it will confirm that institutional buyers are skeptical. If it prices at the upper end, the sell rating will become a dead weight on post-listing performance. Either way, the message is clear: the easy money in the “India trade” has been made. From here, selective asset allocation matters more than thematic conviction.
I’ll close with a signature that applies perfectly: “History doesn’t repeat, but it rhymes.” The rhyme here is the 2017 ICO boom, the 2022 Terra collapse, and now the NSE IPO. In each case, the crowd converges on a single narrative, and a lonely analyst whispers that the emperor has no clothes. The question isn’t whether the sell rating is right—it’s whether the market is ready to listen. If you’re an allocator looking at this IPO, ask yourself: Is the price of admission into India’s story already too high? Based on structural analysis, the answer is likely yes.
